Communiqués
de presse

16 Janvier – SYNTHELIS, l’expert français de la technologie de bioproduction acellulaire (cell-free technology) annonce la signature le 25 Novembre 2023, d’un accord portant sur son rachat au profit de Vincent Poher, un entrepreneur grenoblois spécialiste du diagnostic in-vitro. Synthelis est ainsi devenue SYNTHELIS BIOTECH depuis cette date.

9 Mars – SYNTHELIS and A5 Science have signed a strategic partnership to offer their clients a joint offering of custom production followed by validation of the protein folding and conformation using atomic force microscopy imaging. 

12 avril – SYNTHELIS and PEACCEL have signed a strategic partnership to offer their clients a one-stop shop combinant Artificial Intelligence (AI) and Cell-Free lead expression for accelerated drug discovery.